Bionano Genomics, Inc.
BNGO
$1.18
-$0.02-1.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.16M | -31.60M | -26.40M | -38.59M | -74.33M |
| Total Depreciation and Amortization | 9.52M | 9.61M | 9.73M | 9.79M | 13.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.19M | 4.83M | -195.00K | 7.85M | 30.74M |
| Change in Net Operating Assets | -2.03M | -2.14M | 514.00K | 2.28M | 4.48M |
| Cash from Operations | -20.48M | -19.30M | -16.35M | -18.67M | -26.06M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.48M | 6.78M | -12.75M | -13.76M | -14.47M |
| Cash from Investing | 18.48M | 6.78M | -12.75M | -13.76M | -14.47M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -12.22M | -3.45M | -4.95M | -6.94M | -6.62M |
| Issuance of Common Stock | 16.02M | 18.49M | 31.11M | 36.08M | 33.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.15M | -1.23M | -2.12M | -2.81M | -4.36M |
| Cash from Financing | 2.64M | 13.81M | 24.04M | 26.33M | 22.27M |
| Foreign Exchange rate Adjustments | 28.00K | 3.00K | -11.00K | -22.00K | -13.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 669.00K | 1.29M | -5.06M | -6.13M | -18.27M |